Top

BMC Cardiovascular Disorders

Published in:

Open Access 01-12-2016 | Research article

Effects of lifestyle intervention using patient-centered cognitive behavioral therapy among patients with cardio-metabolic syndrome: a randomized, controlled trial

Authors: Ying Zhang, Songli Mei, Rui Yang, Ling Chen, Hang Gao, Li Li

Published in: BMC Cardiovascular Disorders | Issue 1/2016

Abstract

Background

Cardio-metabolic syndrome (CMS) is a highly prevalent condition. There is an urgent need to identify effective and integrated multi-disciplinary approaches that can reduce risk factors for CMS.

Methods

Sixty-two patients with a history of CMS were randomized 1:1 into two groups: a standard information -only group (control), or a self-regulated lifestyle waist circumference (patient-centered cognitive behavioral therapy) intervention group. A pretest and posttest, controlled, experimental design was used. Outcomes were measured at the baseline (week 0) and at the end of intervention (week 12). Comparisons were drawn between groups and over time.

Results

The mean (standard deviation) age of the subjects was 48.6 (5.8) years ranging from 32 to 63, and 56.9% of the participants were female. Both groups showed no significant differences in Demographic variables and the metabolic syndrome indicators at baseline. While the control group only showed modest improvement after 12 weeks, compared to baseline, the intervention group demonstrated significant improvement from baseline. This study controlled for patients’ demographics and baseline characteristics when assessing the effects of intervention. After adjusting for age, education and baseline level, the experimental group and the control group were statistically significant different in the following post-treatment outcomes: WC (F = 35.96, P < 0.001), TG (F = 18.93, P < 0.001), RSBP (F = 33.89, P < 0.001) and SF-36(F = 157.93, P < 0.001). The results showed patients’ age and education were not strong predictors of patients’ outcome (including WC, TG, RSBP and SF-36).

Conclusions

Lifestyle intervention on patient-centered cognitive behavioral therapy can improve the physical and mental health conditions among individuals reporting a history of cardio-metabolic syndrome, and possibly provided preliminary benefits for the treatment of CMS.

Trial registration

Chinese Clinical Trial Register #, ChiCTR15006148.

Xi B, He D, Hu Y, Zhou D. Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: The China Health and Nutrition Survey in 2009. Prev Med. 2013;57(6):867–71.CrossRefPubMedPubMedCentral

Xiao J-J, Chen Y-H. Prevalence of cardiovascular diseases in China. Front Med China. 2010;4(1):16–20.CrossRef

Dominguez LJ, Barbagallo M. The cardiometabolic syndrome and sarcopenic obesity in older persons. J Cardiometab Syndr. 2007;2(3):183–9.CrossRefPubMed

Krebs-Smith SM, Guenther PM, Subar AF, et al. Americans do not meet federal dietary recommendations. J Nutr. 2010;140(10):1832–8.

Gruber A, Horwood F, Sithole J, Ali N, Idris I. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol. 2006;5(1):22.CrossRefPubMedPubMedCentral

Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation. 2004;109(3):433–8.CrossRefPubMed

Neylon A, Canniffe C, Anand S, Kreatsoulas C, Blake GJ, Sugrue D, et al. A global perspective on psychosocial risk factors for cardiovascular disease. Prog Cardiovasc Dis. 2013;55(6):574–81.CrossRefPubMed

Lorenzo C, Williams K, Hunt KJ, Haffner SM. Trend in the Prevalence of the Metabolic Syndrome and Its Impact on Cardiovascular Disease Incidence The San Antonio Heart Study. Diabetes Care. 2006;29(3):625–30.CrossRefPubMed

Waxman A. Why a global strategy on diet, physical activity and health? Nutrition and Fitness: Mental Health, Aging, and the Implementation of a Healthy Diet and Physical Activity Lifestyle. Karger Publishers. 2005;95:162–6.

10.

Crawford R. Health as a meaningful social practice. Health. 2006;10(4):401–20.CrossRefPubMed

11.

Keyes CL. Promoting and protecting mental health as flourishing: a complementary strategy for improving national mental health. Am Psychol. 2007;62(2):95.CrossRefPubMed

12.

World Health Organization. Global Recommendations on Physical Activity for Health. Geneva; 2010. 2013.

13.

Everitt H, Landau S, Little P, Bishop FL, McCrone P, O'Reilly G, et al. Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome in adults. BMJ Open. 2015;5(7):e008622.CrossRefPubMedPubMedCentral

14.

Tang TS, Gillard ML, Funnell MM, Nwankwo R, Parker E, Spurlock D, et al. Developing a New Generation of Ongoing Diabetes Self-management Support Interventions A Preliminary Report. Diabetes Educ. 2005;31(1):91–7.CrossRefPubMed

15.

Tsai AG, Wadden TA. Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med. 2005;142(1):56–66.CrossRefPubMed

16.

Sniehotta FF, Schwarzer R, Scholz U, Schüz B. Action planning and coping planning for long‐term lifestyle change: theory and assessment. Eur J Soc Psychol. 2005;35(4):565–76.CrossRef

17.

McMullen CK, Safford MM, Bosworth HB, Phansalkar S, Leong A, Fagan MB, et al. Patient-centered priorities for improving medication management and adherence. Patient Educ Couns. 2015;98(1):102–10.CrossRefPubMed

18.

Epstein RM, Franks P, Fiscella K, Shields CG, Meldrum SC, Kravitz RL, et al. Measuring patient-centered communication in patient–physician consultations: theoretical and practical issues. Soc Sci Med. 2005;61(7):1516–28.CrossRefPubMed

19.

Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140–9.CrossRefPubMed

20.

Lambert BL, Levy NA, Winer J, Montagne M, Olfson M, Rucker D, et al. Keeping the balance and monitoring the self-system: towards a more comprehensive model of medication management in psychiatry. Communication and the Management of Health and Illness Mahwah. NJ: Erlbaum; 2009.

21.

Matarazzo JD. Behavioral health and behavioral medicine: frontiers for a new health psychology. Am Psychol. 1980;35(9):807.CrossRefPubMed

22.

Bischoff S, Damms-Machado A, Betz C, Herpertz S, Legenbauer T, Löw T, et al. Multicenter evaluation of an interdisciplinary 52-week weight loss program for obesity with regard to body weight, comorbidities and quality of life—a prospective study. Int J Obes (Lond). 2012;36(4):614–24.CrossRef

23.

Bianchini JAA, da Silva DF, Nardo CCS, Carolino IDR, Hernandes F, Junior NN. Multidisciplinary therapy reduces risk factors for metabolic syndrome in obese adolescents. Eur J Pediatr. 2013;172(2):215–21.CrossRefPubMed

24.

de Groot M, Doyle T, Kushnick M, Shubrook J, Merrill J, Rabideau E, et al. Can lifestyle interventions do more than reduce diabetes risk? Treating depression in adults with type 2 diabetes with exercise and cognitive behavioral therapy. Curr Diab Rep. 2012;12(2):157–66.CrossRefPubMedPubMedCentral

25.

Masheb RM, Grilo CM, Rolls BJ. A randomized controlled trial for obesity and binge eating disorder: low-energy-density dietary counseling and cognitive-behavioral therapy. Behav Res Ther. 2011;49(12):821–9.CrossRefPubMedPubMedCentral

26.

Lingyan J, Zhenshan J. Research Progress of Diagnostic Criteria of Central Obesity and its Application in Metabolic Syndrome. Chin J Prev Contr Chron Dis. 2011;19(3):314–7.

27.

Lossnitzer N, Herzog W, Schultz JH, Taeger T, Frankenstein L, Wild B. A patient-centered perspective of treating depressive symptoms in chronic heart failure: What do patients prefer? Patient Educ Couns. 2015;98(6):783–7.CrossRefPubMed

28.

Committee QHC. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: Institute of Medicine; 2001.

29.

Goyal M, Singh S, Sibinga EM, Gould NF, Rowland-Seymour A, Sharma R, et al. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Intern Med. 2014;174(3):357–68.CrossRefPubMedPubMedCentral

30.

Reynard AK, Sullivan AB, Rae-Grant A. A systematic review of stress-management interventions for multiple sclerosis patients. International journal of MS care. 2014;16(3):140–4.

31.

Eherer A. Management of Gastroesophageal Reflux Disease: Lifestyle Modification and Alternative Approaches. Dig Dis. 2014;32(1–2):149–51.CrossRefPubMed

32.

Pâquet M, Bolduc N, Xhignesse M, Vanasse A. Re‐engineering cardiac rehabilitation programmes: considering the patient's point of view. J Adv Nurs. 2005;51(6):567–76.CrossRefPubMed

33.

Kim CJ, Park JW, Park HR. Effects of a community‐based intervention on cardio‐metabolic risk and self‐care behaviour in older adults with metabolic syndrome. Int J Nurs Pract. 2014;20(2):212–20.CrossRefPubMed

34.

Ware JH. Interpreting incomplete data in studies of diet and weight loss. N Engl J Med. 2003;348(21):2136.CrossRefPubMed

35.

Leite N, Milano G, Cieslak F, Lopes W, Rodacki A, Radominski R. Effects of physical exercise and nutritional guidance on metabolic syndrome in obese adolescents. Brazilian Journal of Physical Therapy. 2009;13(1):73–81.CrossRef

36.

Hobkirk JP, King RF, Gately P, Pemberton P, Smith A, Barth JH, et al. Longitudinal factor analysis reveals a distinct clustering of cardiometabolic improvements during intensive, short-term dietary and exercise intervention in obese children and adolescents. Metab Syndr Relat Disord. 2012;10(1):20–5.CrossRefPubMed

37.

Gerstel E, Pataky Z, Busnel C, Rutschmann O, Guessous I, Zumwald C, et al. Impact of lifestyle intervention on body weight and the metabolic syndrome in home-care providers. Diabetes Metab. 2013;39(1):78–84.CrossRefPubMed

38.

Park ER, Traeger L, Vranceanu A-M, Scult M, Lerner JA, Benson H, et al. The development of a patient-centered program based on the relaxation response: The relaxation response resiliency program (3RP). Psychosomatics. 2013;54(2):165–74.CrossRefPubMed

39.

Imayama I, Ulrich CM, Alfano CM, Wang C, Xiao L, Wener MH, et al. Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res. 2012;72(9):2314–26.CrossRefPubMedPubMedCentral

40.

Salas-Salvad J, Bull M, Babio N, Martinez-Gonzalez M, Ibarrola-Jurado N, Basora J, et al. Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet Results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care. 2011;34(1):14–9.CrossRef

41.

Magkos F, Yannakoulia M, Chan JL, Mantzoros CS. Management of the metabolic syndrome and type 2 diabetes through lifestyle modification. Annu Rev Nutr. 2009;29:223–56.CrossRefPubMed

42.

Greenfield G, Ignatowicz AM, Belsi A, Pappas Y, Car J, Majeed A, et al. Wake up, wake up! It’s me! It’s my life! patient narratives on person-centeredness in the integrated care context: a qualitative study. BMC Health Serv Res. 2014;14(1):619.CrossRefPubMedPubMedCentral

43.

Teixeira PJ, Silva MN, Mata J, Palmeira AL, Markland D. Motivation, self-determination, and long-term weight control. Int J Behav Nutr Phys Act. 2012;9(1):22.CrossRefPubMedPubMedCentral

44.

Cottraux J. Behavioral Psychotherapy Applications in the Medically. Psychotherapy and psychosomatics. 1993;60(3-4):116–28.

45.

Redon J, Cifkova R, Laurent S, Nilsson P, Narkiewicz K, Erdine S, et al. The metabolic syndrome in hypertension: European society of hypertension position statement. J Hypertens. 2008;26(10):1891–900.CrossRefPubMed

46.

Kushner RF. Clinical assessment and management of adult obesity. Circulation. 2012;126(24):2870–7.CrossRefPubMed

47.

Harris AH, Luskin F, Norman SB, Standard S, Bruning J, Evans S, et al. Effects of a group forgiveness intervention on forgiveness, perceived stress, and trait‐anger. J Clin Psychol. 2006;62(6):715–33.CrossRefPubMed

48.

Haas L, Maryniuk M, Beck J, Cox CE, Duker P, Edwards L, et al. National standards for diabetes self-management education and support. Diabetes Care. 2013;36(Supplement 1):S100–8.CrossRefPubMed

49.

Glass TA, McAtee MJ. Behavioral science at the crossroads in public health: extending horizons, envisioning the future. Soc Sci Med. 2006;62(7):1650–71.CrossRefPubMed

50.

Wierzbicki AS, Hubbard J, Botha A. A renaissance for cardio‐metabolic surgery: better outcomes and lower costs? Int J Clin Pract. 2011;65(7):728–32.CrossRefPubMed

51.

Patel V. Understanding the integration of alternative modalities into an emerging healthcare model in the United States. Alternative medicine and ethics. Alternative medicine and ethics. Humana Press; 1998. p. 43–95.

Title: Effects of lifestyle intervention using patient-centered cognitive behavioral therapy among patients with cardio-metabolic syndrome: a randomized, controlled trial
Authors: Ying Zhang
Songli Mei
Rui Yang
Ling Chen
Hang Gao
Li Li
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: BMC Cardiovascular Disorders / Issue 1/2016
Electronic ISSN: 1471-2261
DOI: https://doi.org/10.1186/s12872-016-0398-9

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effects of lifestyle intervention using patient-centered cognitive behavioral therapy among patients with cardio-metabolic syndrome: a randomized, controlled trial

Abstract

Background

Methods

Results

Conclusions

Trial registration

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2016

Rationale and design of a randomised clinical trial for an extended cardiac rehabilitation programme using telemonitoring: the TeleCaRe study

Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study

Prostatic abscess in a patient with ST-elevation myocardial infarction: a case report

Vascular structure and function and their relationship with health-related quality of life in the MARK study

Serum levels of C1q/TNF-related protein-1 (CTRP-1) are closely associated with coronary artery disease

Assessment of the longitudinal changes in infarct heterogeneity post myocardial infarction

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page